'Diabetes Care' devotes December issue to insulin's importance, applications
Diabetes Care recently published new reports on diabetes.
"Although insulin has always been the mainstay of type 1 diabetes treatment, we recognize now its effectiveness and safety in type 2 diabetes and continue to learn to use it in new ways," Dr. William Cefalu, editor-in-chief of Diabetes Care, said. "Over the years, many changes in insulin therapy have occurred, including new formulations, new delivery systems and additional therapeutic tactics. We are on the brink of a new and exciting era with increasingly reliable and easy-to-use continuous glucose monitoring as part of a closed-loop delivery system."
The magazine wrote an editorial about the subject in their new December addition.
"To a great extent, the newer classes of glucose-lowering agents are being studied as 'add-on' tactics on a background of insulin rather than as a replacement for insulin in subjects with type 2 diabetes," the article concluded. "Thus, we think insulin is and will continue to hold the place of the 'black dress' among therapies … meeting a basic need, never out of fashion and always adaptable to everyday needs."
Organizations in this story
American Diabetes Association 2080 Silas Deane Hwy Rocky Hill, CT 06067